An FDA warning letter to Purolea Cosmetics Lab shows that AI-assisted drafting can support documentation work only when the resulting document is subject to quality-system controls.
Svyatoslav Borshchenko
Advertisement
Svyatoslav Borshchenko is CEO and cofounder, GxPilot.
Articles by Svyatoslav Borshchenko
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
2
argenx Agrees to Buy Unnatural Products in Up to $1.15 Billion Deal
3
Amgen Real-World Study Links Evolocumab to Lower Heart Attack Risk Than Ezetimibe
4
UCB Reports 24-Week Bimekizumab (Bimzelx) vs Risankizumab Data in PsA
5